Loading
AC
Avagenesis Corp. Stock: price and insider trades · Canada
Avagenesis Corp.: what insiders have been doing
We have very little insider data for Avagenesis Corp. so far: the most recent filing dates from 26 October 2016. With so few records, no pattern can be drawn yet. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 26 October 2016
Declarations6 total
200,000 shares@ CA$0.25100.0% of flowCommon SharesTSXSEDI:2905878
100,000 shares@ CA$0.25100.0% of flowCommon SharesTSXSEDI:2905211
100,000 shares@ CA$0.25100.0% of flowCommon SharesTSXSEDI:2904789
Common SharesTSXSEDI:2784240
177,419 shares@ CA$0.3153.3% of flowCommon SharesTSXSEDI:2784241
155,221 shares@ CA$0.3146.7% of flowCommon SharesTSXSEDI:2784242
6 of 6 declarations
About Avagenesis Corp.
Avagenesis Corp. is a company listed on the XTSE, focused on developing innovative solutions in the biotechnology sector.
